Trade Summary

2 days ago, Smith Mervin, serving as EVP Strategic Business Ops at Irhythm Holdings, Inc. (IRTC), sold 4,041 shares at $135.42 per share, for a total transaction value of $547,228.00. Following this transaction, Smith Mervin now holds 20,275 shares of IRTC.

This sale represents a 17.00% decrease in Smith Mervin's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Wednesday, February 25, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, February 26, 2026, 1 day after the trade was made.

Irhythm Holdings, Inc. operates in the HEALTHCARE sector, specifically within the MEDICAL DEVICES industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.